<DOC>
	<DOCNO>NCT01004263</DOCNO>
	<brief_summary>To provide long term safety data rizatriptan child adolescent . The primary hypothesis study rizatriptan well tolerate long term treatment acute migraine pediatric patient age 12-17 year .</brief_summary>
	<brief_title>A Study Evaluate Safety Tolerability Rizatriptan Long Term Treatment Acute Migraine Children Adolescents ( MK-0462-086 AM3 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Patient 12 17 year age inclusive screen Visit 1 Patient weighs least 20 kg ( 44 pound ) Patient history unilateral bilateral migraine headache without aura &gt; 6 month ≥1 ≤8 mild , moderate severe migraine attack per month 2 month prior screen Visit 1 Patient history migraine define International Headache Society ( IHS ) migraine definitions The parent guardian patient agree patient 's participation study indicate parental/guardian signature consent form patient assent For patient take migraine prophylactic medication , treatment regimen stable take least 3 month prior Visit 1 Patient pregnant breastfeeding , female expect conceive within project duration study participation Patient history mild migraine attack migraine resolve less 2 hour Patient basilar hemiplegic migraine headache Patient &gt; 15 headachedays per month OR take medication acute headache 10 day per month 3 month prior screen Patient uncontrolled high blood pressure , uncontrolled diabetes , human immunodeficiency virus ( HIV ) , cancer , significant disease Patient history cardiovascular problem stroke Patient either demonstrate hypersensitivity experience serious adverse event response rizatriptan Patient demonstrate hypersensitivity experience serious adverse event response 3 class drug ( overthecounter prescription ) Patient experience satisfactory relief migraine pain prior treatment 2 adequate course 5hydroxytryptamine 1 ( 5HT1 ) agonist Patient recent history ( within past year ) current evidence drug alcohol abuse `` recreational user '' illicit drug Patient currently take monoamine oxidase inhibitor , methysergide , propranolol , unable tolerate withdrawal medication interval require Patient currently participate participate study investigational compound device within 30 day screen Patient legally mentally incapacitated</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>acute migraine without aura adolescent</keyword>
</DOC>